BusinessAxim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid Delivery Method for Treatment of Irritable Bowel Syndrome (IBS)By Nasdaq OMXNov 21, 2017, 2:00 PM UTC
BusinessCannabis Technology: How Entrepreneurs Can Maximize Contribution to a Rapidly Expanding IndustryBy Nasdaq OMXNov 21, 2017, 2:00 PM UTC
BusinessMariMed Expands to Maryland with Opening of Cannabis Cultivation Facility in HagerstownBy Nasdaq OMXNov 21, 2017, 1:00 PM UTC
BusinessEmerald Health Therapeutics Completes Investment in Licensed Dealer Northern VineBy Nasdaq OMXNov 21, 2017, 12:00 PM UTC
BusinessStreetwise Reports Examines An AgriTech Company Selling to Organic and Cannabis MarketsBy Nasdaq OMXNov 20, 2017, 2:01 PM UTC
BusinessEmerald Health Therapeutics Appoints Robert C. Hill, CPA, CA as Chief Financial Officer and Promotes Cheryl Evans, CPA, CA to Vice President FinanceBy Nasdaq OMXNov 20, 2017, 1:31 PM UTC
BusinessBeleave Announces $5 Million Non-Brokered Private Placement of UnitsBy Nasdaq OMXNov 20, 2017, 12:25 PM UTC
BusinessTHC Therapeutics in Partnership With ADVFN Announces Formation of New Company - MJAC Investorshub International Conferences LtdBy Nasdaq OMXNov 20, 2017, 12:20 PM UTC
